Trials / Conditions / Refractory Malignancy
Refractory Malignancy
4 registered clinical trials studyying Refractory Malignancy.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Study of the Pharmacokinetics/Safety of Sorafenib + Capecitabine in Advanced Solid Tumors NCT00613145 | SCRI Development Innovations, LLC | Phase 1 |
| Completed | Phase I Study of Patupilone and RAD001 NCT00496600 | University of Medicine and Dentistry of New Jersey | Phase 1 |
| Completed | PTK787/ZK222584 With Bevacizumab in Patients With Refractory and/or Advanced Malignancies NCT00611793 | SCRI Development Innovations, LLC | Phase 1 |
| Completed | Imatinib and PTK787/ZK222584 in Refractory and/or Advanced Solid Tumors NCT00611689 | SCRI Development Innovations, LLC | Phase 1 |